TABLE 3.
Needle type | |||
Umbrella-shaped | Single needle | Total | |
N = 25 | N = 5 | N = 30 | |
Patients with at least one AE [n (%)] | 18 (72%) | 2 (40%) | 20 (66.7%) |
Patients with at least one serious AE [n (%)] | 5 (20%) | 0 (0%) | 5 (16.7%) |
Patients with at least one RFA-related AE [n (%)] | 11 (44%) | 0 (0%) | 11 (36.7%) |
Patients with at least one serious RFA-related AE [n (%)] | 2 (8%) | 0 (0%) | 2 (7%) |
Safety-specific secondary outcomes | |||
Pneumothorax | 3 | 0 | 3 |
Transient post-RFA pain | 3 | 0 | 3 |
Retroperitoneal hematoma | 0 | 0 | 1 |
Infection | 0 | 0 | 1 |
Number of RFA-related AEs (n = 14)a | |||
Pneumothorax | 3 | 0 | 3 |
Transient post-RFA pain | 3 | 0 | 3 |
Dorsalgia | 1 | 0 | 1 |
Renal polar arterial injury | 1 | 0 | 1 |
Chest painc | 1 | 0 | 1 |
Malaise | 1 | 0 | 1 |
Small adjacent hepatic RF injury | 1 | 0 | 1 |
Chronic kidney failureb | 1 | 0 | 1 |
Acute kidney failureb | 1 | 0 | 1 |
Vomiting | 1 | 0 | 1 |
RFA, radiofrequency ablation.
Fourteen (14) RFA-related adverse events (AE)s in 11 patients.
Acute and chronic kidney failure were declared for the same patient.
Chest pain was a ‘serious’ event leading to the prolongation of hospitalization.